Future Targeted Disease Modifying Drugs for Alzheimer's Disease

E-ISSN： 2212-3954|6|1|65-76

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.6, Iss.1, 2011-01, pp. : 65-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disease-modifying drugs in multiple sclerosis: a review of expenditure in Ireland

By Bailey B.

Irish Journal of Medical Science, Vol. 180, Iss. 2, 2011-06 ,pp. : 337-341

Springer Publishing Company

Access to resources Recommend Favorite

Persistence and adherence to disease modifying drugs among patients with multiple sclerosis

By Reynolds Matthew W. Stephen Reejis Seaman Chris Rajagopalan Kitty

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 663-674

Informa Healthcare

Access to resources Recommend Favorite

Patients' Considerations in the Decision‐Making Process of Initiating Disease‐Modifying Antirheumatic Drugs

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 7, 2015-07 ,pp. : 956-964

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cholesterol-lowering drugs and Alzheimer’’s disease

By Eckert Gunter P Müüller Walter E Wood W Gibson

Future Lipidology, Vol. 2, Iss. 4, 2007-08 ,pp. : 423-432

Future Medicine

Access to resources Recommend Favorite

Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease‐Modifying Antirheumatic Drugs

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 12, 2015-12 ,pp. : 1671-1678

John Wiley & Sons Inc

Access to resources Recommend Favorite